Verma et al., J Biol Chem 2002
:
In a similar manner, transforming growth factor beta , which also exhibits inhibitory effects on normal hematopoiesis, activates p38 and MapKapK-2 in human hematopoietic progenitors, whereas pharmacological inhibitors of p38 reverse its suppressive activities on both myeloid and erythroid colony formation
Sato et al., J Invest Dermatol 2002
(Scleroderma, Systemic) :
Ectopic expression of p38alpha enhanced COL1A2 promoter activity and potentiated transforming growth factor beta stimulation of this promoter
Kinugawa et al., Mol Endocrinol 2005
(Hypertrophy) :
The mechanism of TH and TRalpha1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta activated kinase ( TAK1 ) and p38 Huang et al., Cancer Res 2005
(Prostatic Neoplasms) :
We have also shown that p38 mitogen activated protein kinase ( MAPK ) is necessary for transforming growth factor beta ( TGF-beta ) -mediated increases in prostate cancer adhesion